MSI1通过同源重组修复、肿瘤侵袭和癌症干样细胞特性与胶质母细胞瘤放疗抵抗相关
该研究通过两轮照射和侵袭实验从患者来源的胶质母细胞瘤(GBM)细胞中纯化出放疗抵抗的R2M2细胞,发现MSI1高表达。沉默MSI1或诱导过表达后评估DNA损伤反应,发现MSI1通过VCAM1增强肿瘤侵袭,并通过增加同源重组修复和逃逸凋亡过度激活DNA损伤反应来调节放疗抵抗。MSI1抑制可能使肿瘤放射增敏、防止放疗诱导的癌症干样细胞阳性选择并减少肿瘤侵袭。
要点
- MSI1通过VCAM1增强GBM肿瘤侵袭。
- MSI1通过增加同源重组修复和逃逸凋亡过度激活DNA损伤反应来调节放疗抵抗。
- MSI1抑制可能使肿瘤放射增敏、防止放疗诱导的癌症干样细胞阳性选择并减少肿瘤侵袭。
核心结论
- MSI1可能参与调节GBM的放疗抵抗、侵袭和复发,并可能成为GBM治疗的新靶点。
研究设计与样本
- 研究使用照射处理患者来源的GBM(Par)细胞,并通过两轮照射和侵袭实验纯化出放疗抵抗的GBM(R2M2)细胞。
- 通过沉默MSI1高表达的R2M2细胞系或在MSI1低/无表达的Par细胞系中诱导过表达,评估后续DNA损伤反应。
主要发现
- MSI1通过VCAM1增强肿瘤侵袭。
- MSI1通过增加同源重组修复和逃逸凋亡过度激活DNA损伤反应来调节GBM放疗抵抗。
- MSI1敲低诱导受照射GBM细胞中DNA损伤积累并促进其体外耗竭。
- MSI1敲低还抑制由受照射异种移植细胞生成的GBM形成。
临床怎么用
- MSI1抑制可能使肿瘤放射增敏、防止放疗诱导的癌症干样细胞阳性选择并减少肿瘤侵袭。
- MSI1可能成为GBM治疗的新靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Glioblastoma multiforme (GBM) is the most common brain malignancy in adults, and currently available GBM treatments present several unique challenges. It is known that GBM involves cancer stem-like cells (CSCs) and tumor cells that aggressively invade normal brain tissues, and both cell types may cause resistance to radiotherapy (RT) and are thus responsible for therapeutic failure. The radioresistance of GBM cells relies on the efficient activation of the DNA damage response (DDR), but the mechanisms linking this response with stem-cell status and tumor invasion remain unclear. MATERIALS AND METHODS: We used irradiation to treat patient-derived GBM (Par) cells and then purified radioresistant GBM (R2M2) cells through two rounds of irradiation and an invasion assay. Musashi-1 (MSI1) is a neural stem-cell marker and key oncogenic factor of GBM. We identified MSI1 expression to predict radioresistance through silencing an MSI1-high-expressing R2M2 cell line or inducing overexpression in a Par cell line with low/no MSI1 expression and assessing the subsequent DDR. RESULT: MSI1 enhances tumor invasion via VCAM1 and modulates GBM radioresistance via the hyperactivation of the DDR through increasing homologous recombination repair and evading apoptosis. MSI1 knockdown induces DNA damage accumulation in irradiated GBM cells and promotes their depletion in vitro; MSI1 knockdown also inhibits the formation of GBMs generated by irradiated xeno-transplanted cells. MSI1 inhibition may radiosensitize tumors, prevent CSC-positive selection induced by RT, and reduce tumor invasion. CONCLUSION: MSI1 may involve in regulating GBM radioresistance, invasion, and recurrence and could be a novel target for GBM treatment.
引用
- Lin JC, Tsai JT, Chao TY, et al. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties. Radiother Oncol. 2018. PMID: 30322656. doi:10.1016/j.radonc.2018.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。